{"DataElement":{"publicId":"6617399","version":"1","preferredName":"Malignant Neoplasm Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding Bone Lesion Uptake Status","preferredDefinition":"Status of FDG-PET uptake at bone lesion site(s).","longName":"BN_LSN_FDG_PET_UPTAKE_ST","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3871876","version":"1","preferredName":"Malignant Neoplasm Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding","preferredDefinition":"information related to the uptake or abosorbtion of Fludeoxyglucose F 18 (FDG), the radioactive form of glucose used in positron emission tomography (PET) assessment, of a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"LsnFDGPETUptake","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3871874","version":"1","preferredName":"Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding","preferredDefinition":"The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.:A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:Having determined the value, significance, or extent of.:Clinical, laboratory or molecular evidence, or absence of evidence of disease. ","longName":"3871874v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fludeoxyglucose F-18","conceptCode":"C964","definition":"A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5328507-4DD8-E213-E040-BB89AD434BBE","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5328507-4DE9-E213-E040-BB89AD434BBE","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6617395","version":"1","preferredName":"Bone Lesion Uptake Status","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Lacking in hardness relatively or comparatively._An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._A condition or state at a particular time._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.","longName":"6617395v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"New lesion that is FDG-PET avid","valueDescription":"New lesion that is FDG-PET avid","ValueMeaning":{"publicId":"6617396","version":"1","preferredName":"New lesion that is FDG-PET avid","longName":"6617396","preferredDefinition":"New lesion that is FDG-PET avid","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA9E12C-8BDE-6710-E053-F662850A0DCB","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FA9E12C-8BF7-6710-E053-F662850A0DCB","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"FDG-PET uptake resolved completely","valueDescription":"FDG-PET uptake resolved completely","ValueMeaning":{"publicId":"6617398","version":"1","preferredName":"FDG-PET uptake resolved completely","longName":"6617398","preferredDefinition":"FDG-PET uptake resolved completely","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA9E12C-8C24-6710-E053-F662850A0DCB","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FA9E12C-8C3D-6710-E053-F662850A0DCB","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"50% or greater reduction in number of FDG-PET avid bone lesions","valueDescription":"50% or greater reduction in number of FDG-PET avid bone lesions","ValueMeaning":{"publicId":"6629808","version":"1","preferredName":"50% or greater reduction in number of FDG-PET avid bone lesions","longName":"6629808","preferredDefinition":"50% or greater reduction in number of FDG-PET avid bone lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80D9D6C4-E829-1047-E053-F662850AA755","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-02-01","modifiedBy":"ONEDATA","dateModified":"2019-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80D9D6C4-E842-1047-E053-F662850AA755","beginDate":"2019-02-01","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-02-01","modifiedBy":"ONEDATA","dateModified":"2019-02-01","deletedIndicator":"No"},{"value":"0-50% reduction in number of FDG-PET avid bone lesions","valueDescription":"0-50% reduction in number of FDG-PET avid bone lesions","ValueMeaning":{"publicId":"7755262","version":"1","preferredName":"0-50% reduction in number of FDG-PET avid bone lesions","longName":"7755262","preferredDefinition":"0-50% reduction in number of FDG-PET avid bone lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C883F0F4-9C88-11D4-E053-4EBD850AE444","latestVersionIndicator":"Yes","beginDate":"2021-08-01","endDate":null,"createdBy":"LAMEMIL","dateCreated":"2021-08-01","modifiedBy":"ONEDATA","dateModified":"2021-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C883F0F4-9CA1-11D4-E053-4EBD850AE444","beginDate":"2021-08-01","endDate":null,"createdBy":"LAMEMIL","dateCreated":"2021-08-01","modifiedBy":"ONEDATA","dateModified":"2021-08-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6617394","version":"1","preferredName":"Uptake Bone Lesion Status","preferredDefinition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.:A condition or state at a particular time.","longName":"C71688:C43260:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bone Lesion","conceptCode":"C43260","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA9E12C-8BB6-6710-E053-F662850A0DCB","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA9E12C-8BC7-6710-E053-F662850A0DCB","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"LAMEMIL","dateModified":"2021-09-02","changeDescription":"Curated for ANBL1821","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Yes, specify:","type":"Preferred Question Text","description":"If Yes, specify:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA9DC07-3833-5A63-E053-F662850A0C34","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":"Curated for ANBL1821","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}